My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 328

    1.

    Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation.

    Féray C, Gigou M, Samuel D, Ducot B, Maisonneuve P, Reynès M, Bismuth A, Bismuth H.

    Ann Intern Med. 1998 May 15;128(10):810-6.PMID: 9599192 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.

    Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Kelley M, Bozorgzadeh A.

    Transplant Proc. 2005 Sep;37(7):3187-9.PMID: 16213345 [PubMed - indexed for MEDLINE]Related articles

    3.

    Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.

    Arnold JC, Töx U, Goeser T, Otto G, Müller HM, Hofmann WJ, Stremmel W, Theilmann L.

    Z Gastroenterol. 1997 Apr;35(4):255-61.PMID: 9163889 [PubMed - indexed for MEDLINE]Related articles

    4.

    Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization.

    al-Hemsi B, McGory RW, Shepard B, Ishitani MB, Stevenson WC, McCullough C, Pruett TL.

    Clin Transplant. 1996 Dec;10(6 Pt 2):668-75.PMID: 8996763 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.

    Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons-Romero F.

    Am J Gastroenterol. 1997 Sep;92(9):1458-62.PMID: 9317062 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evolving experience of hepatitis B virus prophylaxis in liver transplantation.

    Honaker MR, Shokouh-Amiri MH, Vera SR, Alloway RR, Grewal HP, Hardinger KL, Kizilisik AT, Bagous T, Trofe J, Stratta RJ, Egidi MF, Gaber AO.

    Transpl Infect Dis. 2002 Sep;4(3):137-43.PMID: 12421458 [PubMed - indexed for MEDLINE]Related articles

    7.

    Outcome of hepatitis B and C virus infection on graft function after renal transplantation.

    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.

    Transplant Proc. 2005 Sep;37(7):3045-7.PMID: 16213299 [PubMed - indexed for MEDLINE]Related articles

    8.

    Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation.

    Bizollon T, Guichard S, Ahmed SN, Chevallier P, Ducerf C, Sepetjan M, Baulieux J, Trepo C.

    J Hepatol. 1998 Dec;29(6):893-900.PMID: 9875635 [PubMed - indexed for MEDLINE]Related articles

    9.

    Incidence and outcome of hepatitis C virus infection after liver transplantation.

    Vargas V, Comas P, Castells L, Quer J, Esteban JI, Allende E, Esteban R, Guardia J, Margarit C.

    Transpl Int. 1994;7 Suppl 1:S216-20.PMID: 11271206 [PubMed - indexed for MEDLINE]Related articles

    10.

    Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.

    Joya-Vazquez PP, Dodson FS, Dvorchik I, Gray E, Chesky A, Demetris AJ, Shakil O, Fung JJ, Vargas HE.

    Transplantation. 2002 May 27;73(10):1598-602.PMID: 12042646 [PubMed - indexed for MEDLINE]Related articles

    11.

    Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.

    Bizollon T, Ahmed SN, Guichard S, Chevallier P, Adham M, Ducerf C, Baulieux J, Trepo C.

    Gut. 2000 Nov;47(5):698-702.PMID: 11034588 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Hepatitis viruses and liver transplantation.

    Samuel D, Feray C, Bismuth H.

    J Gastroenterol Hepatol. 1997 Oct;12(9-10):S335-41. Review.PMID: 9407355 [PubMed - indexed for MEDLINE]Related articles

    13.

    HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis.

    Roche B, Feray C, Gigou M, Roque-Afonso AM, Arulnaden JL, Delvart V, Dussaix E, Guettier C, Bismuth H, Samuel D.

    Hepatology. 2003 Jul;38(1):86-95.PMID: 12829990 [PubMed - indexed for MEDLINE]Related articles

    14.

    Antibody response to hepatitis C virus infection after liver transplantation.

    Hsu HH, Wright TL, Tsao SC, Combs C, Donets M, Feinstone SM, Greenberg HB.

    Am J Gastroenterol. 1994 Aug;89(8):1169-74.PMID: 7519818 [PubMed - indexed for MEDLINE]Related articles

    15.

    Long-term outcome of hepatitis C infection after liver transplantation.

    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.

    N Engl J Med. 1996 Mar 28;334(13):815-20.PMID: 8596547 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.

    Farges O, Saliba F, Farhamant H, Samuel D, Bismuth A, Reynes M, Bismuth H.

    Hepatology. 1996 Feb;23(2):240-8.PMID: 8591847 [PubMed - indexed for MEDLINE]Related articles

    17.

    Serological pattern of hepatitis C virus recurrence after liver transplantation.

    Rehermann B, Seifert U, Tillmann HL, Michel G, Böker KH, Pichlmayr R, Manns MP.

    J Hepatol. 1996 Jan;24(1):15-20.PMID: 8834019 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.

    Rostaing L, Izopet J, Cisterne JM, Icart J, Chabannier MH, Panicali H, Durand D.

    Am J Nephrol. 1997;17(1):46-52.PMID: 9057953 [PubMed - indexed for MEDLINE]Related articles

    19.

    An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.

    Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P.

    Liver Transpl. 2000 Nov;6(6):741-8.PMID: 11084061 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Recurrence of hepatitis caused by hepatitis c virus in patients receiving a liver transplant]

    Crespo J, Casafont F, Carte B, Lozano JL, Fábrega E, Sánchez-Antolín G, Dueñas C, Pons Romero F.

    Med Clin (Barc). 1997 Jan 25;108(3):98-102. Spanish. PMID: 9064439 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity